Key points are not available for this paper at this time.
The US president, Donald Trump, made secret overtures to the German company CureVac—one of the leading contenders to create a covid-19 vaccine—in the hope of luring it to the United States, say senior officials in the German government. Germany’s Welt am Sonntag newspaper reported that the offer, valued at about 1bn (£829m; €912m), stipulated that any vaccine the company developed would be “only for the USA. ”1 The company has often said that its products would be offered to all countries. Senior German officials confirmed the reports and criticised the US government’s actions. Horst Seehofer, interior minister, when asked to confirm the newspaper’s report, said that he had “heard from several other …
Owen Dyer (Tue,) studied this question.